Results 31 to 40 of about 44,747 (260)

Distinct neuropsychological correlates of cognitive, behavioural and affective apathy sub-domains in acquired brain injury.

open access: yesFrontiers in Neurology, 2014
Apathy has a high prevalence and a significant contribution to treatment and rehabilitation outcomes in acquired brain damage. Research on the disorder’s neuropsychological correlates has produced mixed results.
Progress eNjomboro, Shoumitro eDeb
doaj   +1 more source

Prevalent, persistent, and impairing: Longitudinal course and impact of apathy in Alzheimer's disease

open access: yesAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021
Introduction Understanding of the natural history of apathy and its impact on patient function is limited. This study examines, in a large, national sample of Alzheimer's disease (AD) patients with long follow‐ups: (1) prevalence, incidence, and ...
Hillel T. Grossman   +7 more
doaj   +1 more source

Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype

open access: yesBrain Sciences, 2022
Apathy is a neurobehavioural symptom affecting Parkinson’s disease patients of all disease stages. Apathy seems to be associated with a specific underlying non-motor disease subtype and reflects dysfunction of separate neural networks with distinct neurotransmitter systems.
Ségolène De Waele   +2 more
openaire   +4 more sources

Crystal induced arthropathies—a comparative study of 40 patients with apatite rheumatism, chondrocalcinosis and primary synovial chondromatosis

open access: yesPathology and Oncology Research
Introduction: Apatite rheumatism (AR), chondrocalcinosis (Ch-C), and primary synovial chondromatosis (prSynCh) are regarded as distinct clinical entities.
Miklós Bély, Ágnes Apáthy
doaj   +1 more source

White matter hyperintensities: a marker for apathy in Parkinson’s disease without dementia?

open access: yesAnnals of Clinical and Translational Neurology, 2020
Objective The objective of this study was to assess the relationship between white matter hyperintensities (WMH) and the occurrence and progression of apathy in Parkinson’s disease (PD).
Yu Zhang   +5 more
doaj   +1 more source

Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito   +14 more
wiley   +1 more source

The relationship between apathy and impulsivity in large population samples

open access: yesScientific Reports, 2021
Apathy and impulsivity are debilitating conditions associated with many neuropsychiatric conditions, and expressed to variable degrees in healthy people.
Pierre Petitet   +5 more
doaj   +1 more source

Apathy subtypes in acute stroke: validation of the Russian self-rated Dimensional Apathy Scale

open access: yesThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Background Apathy is a syndrome that can occur in a third of stroke patients. It can be measured by the Dimensional Apathy Scale (DAS), not yet utilized in acute stroke or translated to Russian.
Mansur Kutlubaev   +2 more
doaj   +1 more source

Apathy

open access: yesPhilosophical anthropology, 2023
Apathy – a term of ancient philosophy, which was also used by representatives of patristics, medieval scholasticism and New Age philosophy. “Apathy”, de-pending on the understanding of affectability as the ability to undergo an impact, can mean the absence of any suffering (passion, affect), immunity to this or that influence or non-subjection to it ...
openaire   +1 more source

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy